Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 9:27 pm Sale |
2022-12-31 | 13G | Verve Therapeutics, Inc. VERV |
Casdin Capital, LLC | 2,290,571 3.700% |
-847,596 (-27.01%) |
Filing History |
| 2023-02-13 4:08 pm Sale |
2022-12-31 | 13G | Verve Therapeutics, Inc. VERV |
ARCH Venture Fund X L.P. | 0 0.000% |
-2,508,809 (Position Closed) |
Filing History |
| 2023-02-10 4:05 pm Sale |
2022-12-31 | 13G | Verve Therapeutics, Inc. VERV |
GV 2017, L.P. | 10,549,086 17.100% |
-424,925 (-3.87%) |
Filing History |
| 2023-02-10 2:56 pm Purchase |
2022-12-31 | 13G | Farmers & Merchants Bancorp, Inc. FMAO |
BlackRock Inc. BLK |
3,594,074 5.800% |
3,594,074 (New Position) |
Filing History |
| 2023-02-10 2:33 pm Purchase |
2022-12-31 | 13G | Verve Therapeutics, Inc. VERV |
ARK Investment Management LLC | 4,365,830 7.090% |
4,365,830 (New Position) |
Filing History |
| 2023-02-09 12:39 pm Purchase |
2023-02-09 | 13G | Verve Therapeutics, Inc. VERV |
FMR LLC | 6,905,422 11.209% |
511,609 (+8.00%) |
Filing History |
| 2023-02-09 11:35 am Purchase |
2022-12-30 | 13G | Verve Therapeutics, Inc. VERV |
The Vanguard Group | 3,812,024 6.190% |
3,812,024 (New Position) |
Filing History |
| 2023-02-07 1:11 pm Purchase |
2022-12-31 | 13G | Verve Therapeutics, Inc. VERV |
STATE STREET CORP STT |
4,471,049 7.260% |
4,471,049 (New Position) |
Filing History |
| 2023-02-06 2:58 pm Sale |
2022-12-30 | 13G | Verve Therapeutics, Inc. VERV |
Wellington Management Group LLP | 859,102 1.390% |
-3,080,406 (-78.19%) |
Filing History |
| 2022-08-10 08:10 am Purchase |
2022-08-09 | 13G | Verve Therapeutics, Inc. VERV |
FMR LLC | 6,393,813 10.976% |
1,392,331 (+27.84%) |
Filing History |
| 2022-02-14 5:15 pm Purchase |
2021-12-31 | 13G | Verve Therapeutics, Inc. VERV |
GV 2017, L.P. | 10,974,011 22.780% |
10,974,011 (New Position) |
Filing History |
| 2022-02-14 09:27 am Purchase |
2021-12-31 | 13G | Verve Therapeutics, Inc. VERV |
Casdin Capital, LLC | 3,138,167 6.500% |
100,000 (+3.29%) |
Filing History |
| 2022-02-09 1:26 pm Purchase |
2021-12-31 | 13G | Verve Therapeutics, Inc. VERV |
ARCH Venture Fund X L.P. | 2,508,809 5.200% |
2,508,809 (New Position) |
Filing History |
| 2022-02-09 10:01 am Purchase |
2022-02-08 | 13G | Verve Therapeutics, Inc. VERV |
FMR LLC | 5,001,482 10.382% |
159,757 (+3.30%) |
Filing History |
| 2022-02-04 09:24 am Purchase |
2021-12-31 | 13G | Verve Therapeutics, Inc. VERV |
Wellington Management Group LLP | 3,939,508 8.180% |
3,939,508 (New Position) |
Filing History |
| 2022-02-04 08:53 am Sale |
2021-12-31 | 13G | Verve Therapeutics, Inc. VERV |
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 1,871,679 3.890% |
-623,892 (-25.00%) |
Filing History |
| 2022-01-24 08:22 am Purchase |
2022-01-13 | 13G | Verve Therapeutics, Inc. VERV |
SINGER JAMES R | 2,465,000 5.100% |
2,465,000 (New Position) |
Filing History |
| 2021-12-28 12:05 pm Purchase |
2021-12-28 | 13G | Verve Therapeutics, Inc. VERV |
FMR LLC | 4,841,725 10.051% |
1,522,263 (+45.86%) |
Filing History |
| 2021-06-28 08:50 am Purchase |
2021-06-17 | 13G | Verve Therapeutics, Inc. VERV |
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 2,495,571 5.180% |
2,495,571 (New Position) |
Filing History |
| 2021-06-23 11:38 am Purchase |
2021-06-17 | 13G | Verve Therapeutics, Inc. VERV |
Casdin Capital, LLC | 3,038,167 6.600% |
3,038,167 (New Position) |
Filing History |